Medical news
Latest official Indian health and medicine updates for doctors Check the original source and local guidance before use.
CDSCO Approves India’s First Dengue Vaccine, Strengthening National Dengue Prevention Efforts
July 21, 2026
About this update
This AI summary is based on Press Information Bureau, Government of India. The original source link and last refresh date are saved here for you to check.
View official sourceSummary
CDSCO granted marketing authorisation for the live, attenuated tetravalent dengue vaccine (Qdenga, Takeda GmbH) for prevention of dengue in individuals aged 4–60 years. The vaccine is supplied as a freeze‑dried powder for subcutaneous injection; the recommended schedule is two 0.5 mL doses at 0 and 3 months. Approval followed scientific evaluation under the Drugs and Cosmetics Act, 1940 and Rules, 1945, supported by global clinical data and an Indian Phase III safety/immunogenicity study in ages 4–60 years. The re…
Want to read more?
Create a free account to read the saved source details and open the original source link.
Create free account Already registered? Sign inCDSCO Approves India’s First Dengue Vaccine, Strengthening National Dengue Prevention Efforts
July 21, 2026
CDSCO granted marketing authorisation for the live, attenuated tetravalent dengue vaccine (Qdenga, Takeda GmbH) for prevention of dengue in individuals aged 4–60 years. The vaccine is supplied as a freeze‑dried powder for subcutaneous injection; the recommended schedule is two 0.5 mL doses at 0 and 3 months. Approval followed scientific evaluation under the Drugs and Cosmetics Act, 1940 and Rules, 1945, supported by global clinical data and an Indian Phase III safety/immunogenicity study in ages 4–60 years. The re…
About this update
Based on Press Information Bureau, Government of India and saved with the original source record.
View official sourceThese AI summaries are a quick starting point. Check the original source, local guidance and your own clinical judgement before using them.